Impact of Training on Gait and Strength in Stroke Survivors
NCT ID: NCT01818349
Last Updated: 2013-03-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2002-03-31
2007-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objective: To evaluate the impact of an isokinetic-strengthening program, matching the requirements of the affected lower-limb muscle groups involved in the energy generation of gait, to a control intervention, on gait performance and muscle strength.
Hypothesis: The isokinetic training program of the affected lower-limb muscles would produce greater changes in gait performance and strength than a control intervention not aiming at training these muscle groups.
Design: Single-blinded randomized controlled trial.
Participants: A convenient sample of 30 individuals with chronic hemiparesis.
Interventions: Participants were randomly assigned into two groups (n=15), each training three times/week for six weeks. The experimental group trained the affected plantarflexors, hip flexors and extensors concentrically, while the control group trained the affected upper-limb muscles.
Main outcome measures: Baseline values and post-training values, taken at the end of the training program, of maximal voluntary concentric strength, gait speed and peak positive power.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of an Inpatient Home-work Exercise Program on Leg Function After Stroke
NCT00908479
Fitness Intervention Trial for Stroke
NCT00786045
Effects of Treadmill Gait Training With Loading in Individuals With Stroke
NCT02113098
Effectiveness of Paretic Lower Limb Loading During Over-ground Training Among Stroke Survivors
NCT05097391
Gait Perturbations to Improve Balance Post-stroke
NCT04314830
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
isokinetic lower-limb training
3 times/week for 6 weeks
isokinetic lower-limb training
concentric training of the affected plantarflexors, hip flexors and hip extensors
isokinetic uppe-limb training
3 times/week for 6 weeks
isokinetic upper-limb training
concentric training of the affected wrist extensors, elbow flexors and shoulder flexors
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
isokinetic lower-limb training
concentric training of the affected plantarflexors, hip flexors and hip extensors
isokinetic upper-limb training
concentric training of the affected wrist extensors, elbow flexors and shoulder flexors
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* be able to walk 10 meters independently with or without a cane
* present residual weakness at the affected lower limb
* have an activity tolerance of at least two hours with a rest period
Exclusion Criteria
* incontinence
* unstable medical condition
* history of injury
* anesthesia at the lower limbs
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
Université de Montréal
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marie-hélène Milot
professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sylvie Nadeau, PhD
Role: PRINCIPAL_INVESTIGATOR
Université de Montréal
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institut de réadaptation Gingras-Lindsay
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRSC-44059
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.